Table 2. The concentration of short-chain fatty acids (SCFAs) in SD rats with loperamide-induced constipation

Groups1) The concentration of short-chain fatty acids (SCFAs, ppm)
Acetic acid Propionic acid Butyric acid Total SCFAs
G1 965.90±117.38 1,646.50±488.85 77.66±49.61 2,690.05±532.05
G2 673.93±191.19 913.80±816.80 50.45±87.37 1,638.18±645.56
G3 836.04±345.12 1,698.273±960.82 15.06±30.11 2,549.37±1,271.69
G4 1,219.60±203.51* 2,426.44±721.84 27.64±47.87 3,673.67±568.99*
G5 1,207.09±318.78 1,940.17±1,549.11 62.03±124.06 3,209.29±1,371.95
G6 1,292.25±209.91* 2,601.30±921.44 <5 3,893.55±1,031.94*
Values are means±standard deviation (n=10).
G1, normal group; G2, loperamide-induced constipation group; G3, Bacillus subtilis IDCC 1101 and loperamide-induced constipation group; G4, Weizmannia coagulans IDCC 1201 and loperamide-induced constipation group; G5, Clostridium butyricum IDCC 1301 and loperamide-induced constipation group; G6, BIOVITA 3 and loperamide-induced constipation group.
p<0.05 vs. G1
p<0.05 vs. G2.
SD, Sprague-Dawley.